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47
Serotonin plays important roles in the biochemistry of memory, depression, and anxiety disorder;
48 the decline of dopamine levels has been shown to be directly related to Parkinson's disease; 6 γ-
49
Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system. 8
50
Monitoring the expression levels of amine containing metabolites using hyphenated mass 51 spectrometric techniques is essential to study the complex processes of life. However, the detection and ion-pairing reversed phase chromatography-MS. 11, 12 Additionally, capillary zone 57 electrophoresis (CZE) separates free metabolites based on charge-to-size ratio and has been 58 coupled to MS for metabolomics studies.
13-18

59
Mass spectrometry-based quantification is another key component in amine metabolite analysis.
60
For absolute quantification, an isotopic analogue of the analyte ( 2 H-or 13 C-analogues) is spiked 61 into samples as an internal standard. 19, 20 However, the use of isotopic internal standard is usually 
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Optima LC/MS grade acetonitrile, methanol and water, N,N-dimethylformamide (DMF), and 4-108 (4, 6-dimethoxy-1, 3, 5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) were purchased 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript to remove urinary proteins. The flow-through fraction was collected and concentrated to dryness.
143
Dried urinary metabolites from four mice were labeled with 4-plex DiLeu reagents separately, 144 combined at equal ratios, and cleaned up with SCX Ziptips using the same procedures described 145 above. Labeled mouse urine sample was dried down and reconstituted in 0.1% FA in H2O for LC-
146
MS analysis or 0.1% FA in 50% MeOH for CE-MS analysis.
147
Direct infusion ESI-MS and ESI-MS/MS
148
Mixtures of 12 DiLeu labeled metabolite standards (1:1:1:1 ratio and 1:5:2:10 ratio) were re- for the measurement of reporter ion intensity.
161
Reversed phase nanoLC-ESI-MS/MS
162
Reversed phase nanoLC-ESI-MS/MS analyses of labeled metabolite standards and mouse urine 163 samples were conducted using a Waters nanoAcquity ultra-performance liquid chromatography and the cycle time was 0.1s for each SRM channel. In the top 5 data dependent acquisition, a 173 survey scan was followed by three MS 2 scans of each precursor ion within the top 5 intensities.
174
The collision energy was 30 eV and precursor isolation window was ~3 Th. Dynamic exclusion 
CE-ESI-MS/MS
178
An HP Agilent G1600AX 3D CE system was coupled with the Synapt-G2 mass spectrometer 179 using a flow-through microvial CE-ESI-MS interface developed by Maxwell et al. 39 The sample labeled and unlabeled metabolites is shown in Fig. 1 (A 
212
The precursor ion of each labeled compound was isolated by the quadrupole and subjected to CID DiLeu labeled norepinephrine is shown in Fig. 1 (C 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript corrected to account for the losses to, and gains from, other reporter ions. Purity-correction was 221 performed in an excel spreadsheet to correct reporter ion intensities obtained from MS/MS 222 spectra. 38, 40 Correction factors and equations can be found in Fig. S1 (See supporting information).
223
The ratios of reporter ion intensities were then calculated from the corrected values for each 224 metabolite. The results were summarized in the box plots in Fig. 2 analysis with a fold change larger than 10 for most metabolite standards. The extracted ion 247 electropherograms of label free and Dileu labeled 12 metabolite standards are compared in Fig. 4 .
248
The signal intensity was increased by more than 200 fold for alanine after labeling with DiLeu. 
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The reproducibility, linearity and sensitivity of the labeling approach for 12 metabolite standards 266 were tested in comparison with the label free method (Table 1) labeled metabolites migrated at the exact same time in CE-MS/MS analysis ( Fig. S3 A, B) . The 287 extracted ion chromatograms of four tags showed negligible retention time differences in LC- 
MS/MS analysis ( Fig. S3 C, D) , demonstrating the co-elution of isobarically labeled metabolite 289 and the consistency of reporter ion intensity ratios throughout the elution profile.
290
Mouse urine metabolite identification and quantification
291
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523
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